Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)

[1]  E. Nieschlag,et al.  Diagnosis of Male Infertility and Hypogonadism , 2001 .

[2]  E. Nieschlag,et al.  Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. , 1999, The Journal of clinical endocrinology and metabolism.

[3]  S. Davis,et al.  Androgen replacement in women: a commentary. , 1999, The Journal of clinical endocrinology and metabolism.

[4]  C. Bohring,et al.  Serum levels of inhibin B in men with different causes of spermatogenic failure , 1999, Andrologia.

[5]  E. Löyttyniemi,et al.  A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin , 1999, Bone Marrow Transplantation.

[6]  C. Lacroix,et al.  MRI-neuropathological correlations in type 1 lissencephaly , 1998, Neuroradiology.

[7]  E. Wallace,et al.  Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. , 1997, The Journal of clinical endocrinology and metabolism.

[8]  C. Scheibenbogen,et al.  Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. , 1997, Cancer.

[9]  S. Singhal,et al.  Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. , 1996, Bone marrow transplantation.

[10]  J. Sierra,et al.  The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. , 1996, Maturitas.

[11]  A. Mcneilly,et al.  Measurement of dimeric inhibin B throughout the human menstrual cycle. , 1996, The Journal of clinical endocrinology and metabolism.

[12]  W. Levy,et al.  Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. , 1996, Blood.

[13]  A. Goldstone,et al.  Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. , 1996, Bone marrow transplantation.

[14]  J. Radford,et al.  Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Goldman,et al.  Successful pregnancy after allogeneic bone marrow transplantation for chronic myeloid leukaemia , 1994, The Lancet.

[16]  R. Chopra,et al.  The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. , 1993, Blood.

[17]  H. Deeg,et al.  Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation. , 1992, Blood.

[18]  B. Chipps,et al.  Reduction of serum testosterone levels during chronic glucocorticoid therapy. , 1986, Annals of internal medicine.